Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

The Post-Chatbot Era Has Begun

Americans are living in parallel AI universes. For much of the country, AI has come to mean ChatGPT, Google’s AI overviews, and the slop that now clogs social-media feeds. Meanwhile, tech hobbyists ...